» Articles » PMID: 36072413

Clinical Significance of Neuregulin 4, Afamin, and SERPINB1 in Gestational Diabetes Mellitus and Their Relationship with Insulin Resistance

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: This study aims to explore the serum levels of neuregulin 4 (NRG4), afamin (AFM), and serpin family B member 1 (SERPINB1) in gestational diabetes mellitus (GDM) patients and their relationship with insulin resistance.

Method: Serum levels of AFM, SERPINB1, and NRG4 were measured in GDM ( = 58), and non-GDM women ( = 60) using enzyme-linked immunosorbent assay (ELISA) kits. Besides, the serum insulin and glucose levels were also measured followed by calculating the homeostatic model assessment of insulin resistance (HOMA-IR). The correlation was performed using the Pearson analysis.

Results: The increased serum levels of AFM and SERPINB1 were revealed in GDM patients as compared with non-GDM women, accompanied by the lower NRG4 serum level. ROCs for AFM concentrations showed an AUC of 0.629 (95% CI: 0.527∼0.731), 0.832 (95% CI: 0.754∼0.909) for the SERPINB1 serum level, and 0.626 (95% CI: 0.524∼0.728) for the NRG4 serum level. The threshold was 108.05 mg/L, 8.75 ng/mL, and 96.25 ng/mL of AFM, SERPINB1, and NRG4. Moreover, the combined ROC of AFM, SERPINB1, and NRG4 serum levels showed higher sensitivity (72.41%) and specificity (85.00%) for the diagnosis of GDM (AUC = 0.839; 95% CI: 0.764∼0.913). In GDM patients, the Pearson analysis revealed a significant correlation between AFM and SERPINB1 ( = 0.776), AFM and NRG4 ( = -0.799), as well as SERPINB1 and NRG4 ( = -0.783). Moreover, AFM and SERPINB1 serum concentrations in GDM patients were positively related to insulin levels, fasting glucose levels, and HOMA-IR values. However, the SERPINB1 serum level was negatively correlated with serum insulin and glucose levels and HOMA-IR.

Conclusion: Abnormal serum levels of NRG4, AFM, and SERPINB1, as highly sensitive diagnostic tools, are closely related to insulin resistance in GDM patients.

Citing Articles

Predictive Utility of Biochemical Markers for the Diagnosis and Prognosis of Gestational Diabetes Mellitus.

Inthavong S, Jatavan P, Tongsong T Int J Mol Sci. 2024; 25(21).

PMID: 39519218 PMC: 11545977. DOI: 10.3390/ijms252111666.


Low circulating levels of neuregulin 4 as a potential biomarker associated with the severity and prognosis of obesity-related metabolic diseases: a systematic review.

Ziqubu K, Dludla P, Mthembu S, Nkambule B, Mazibuko-Mbeje S Adipocyte. 2024; 13(1):2390833.

PMID: 39162358 PMC: 11340757. DOI: 10.1080/21623945.2024.2390833.


Neuregulin 4 as a novel adipokine in energy metabolism.

Liu Y, Chen M Front Physiol. 2023; 13:1106380.

PMID: 36703934 PMC: 9873244. DOI: 10.3389/fphys.2022.1106380.

References
1.
Takebayashi K, Hara K, Terasawa T, Naruse R, Suetsugu M, Tsuchiya T . Circulating SerpinB1 levels and clinical features in patients with type 2 diabetes. BMJ Open Diabetes Res Care. 2016; 4(1):e000274. PMC: 5128937. DOI: 10.1136/bmjdrc-2016-000274. View

2.
Fagerberg L, Hallstrom B, Oksvold P, Kampf C, Djureinovic D, Odeberg J . Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol Cell Proteomics. 2013; 13(2):397-406. PMC: 3916642. DOI: 10.1074/mcp.M113.035600. View

3.
Lichenstein H, Lyons D, Wurfel M, Johnson D, McGinley M, Leidli J . Afamin is a new member of the albumin, alpha-fetoprotein, and vitamin D-binding protein gene family. J Biol Chem. 1994; 269(27):18149-54. View

4.
Kang H . Sample size determination and power analysis using the G*Power software. J Educ Eval Health Prof. 2021; 18:17. PMC: 8441096. DOI: 10.3352/jeehp.2021.18.17. View

5.
Spradley F . Metabolic abnormalities and obesity's impact on the risk for developing preeclampsia. Am J Physiol Regul Integr Comp Physiol. 2016; 312(1):R5-R12. PMC: 5283940. DOI: 10.1152/ajpregu.00440.2016. View